XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities    
Net loss $ (24,200) $ (6,816)
Adjustments to reconcile net loss to cash used in operating activities:    
Non-controlling interest 18 6
Gain on bargain purchase 0 (283)
Inventory reserve 904 617
Stock based compensation expense 7,300 1,953
Depreciation and amortization 19,399 4,807
Right-of-use assets, non-cash lease expense 1,515 1,242
Derivative mark-to-market adjustment (2,197) 0
Bad debts expense 4,369 933
Deferred income taxes (283) 285
Shares issued for transaction bonuses 889 0
Lease termination and modification losses 184 0
Other non-cash items 1,522 126
Changes in operating assets and liabilities:    
Accounts receivables (12,553) (3,866)
Inventories 955 (2,023)
Prepaid expenses and other current assets (3,009) 51
Deferred costs (3,619) 332
Deferred revenue (99) 222
Accounts payable and accrued expenses (71) 1,498
Lease liabilities (1,856) (1,247)
Accrued severance payable, net 40 91
Net cash used in operating activities (10,792) (2,072)
Cash flows from investing activities    
Acquisition, net of cash assumed 27,531 0
Proceeds from sale of fixed assets 217 0
Capitalized software development costs (4,676) (2,047)
Capital expenditures (10,454) (1,441)
Repayment of loan advanced to external parties 294 0
Net cash (used in)/provided by investing activities 12,912 (3,488)
Cash flows from financing activities    
Repayment of long-term debt (978) (2,656)
Short-term bank debt, net 9,955 4,996
Purchase of treasury stock upon vesting of restricted stock (2,836) (94)
Payment of preferred stock dividend and redemption of preferred stock (90,298) (2,257)
Proceeds from private placement, net 61,851 0
Proceeds from exercise of stock options, net 0 36
Cash paid on dividends to affiliates (6) 0
Net cash from/(used in) financing activities (22,312) 25
Effect of foreign exchange rate changes on cash and cash equivalents (436) 53
Net decrease in cash and cash equivalents, and restricted cash (20,628) (5,482)
Cash and cash equivalents, and restricted cash at beginning of the period 109,664 25,089
Reconciliation of cash and cash equivalents, and restricted cash    
Cash and cash equivalents 24,354 [1] 24,780
Restricted cash 63,074 310
Cash, cash equivalents, and restricted cash 89,036 19,607
Supplemental disclosure of cash flow information:    
Taxes 774 115
Interest 6,262 538
Noncash investing and financing activities:    
Common stock issued for transaction bonus 9 0
Shares issued in connection with MiX Combination $ 362,005 $ 0
[1] Derived from audited balance sheet as of March 31, 2024.